Patent ID: 7407763

Claim:
A method for predicting prostate cancer recurrence, comprising: a) providing a resected or biopsied prostate tissue sample from a subject diagnosed with prostate cancer and a resected or biopsied prostate tissue sample from a control-subject diagnosed with non-metastatic prostate cancer, b) determining the amount of RKIP protein in said prostate tissue sample from said subject and from said control subject, c) comparing said determined amount of RKIP protein in said prostate tissue sample from said subject and said control-subject, and d) providing a prognosis to said subject regarding risk of prostate cancer recurrence after treatment for prostate cancer based upon said comparing of RKIP protein amount in said prostate tissue sample from said subject and from said control-subject, wherein said subject has a higher likelihood of prostate cancer recurrence after treatment for prostate cancer if said subject's determined RKIP protein amount is less than said control-subject's determined RKIP protein amount.